ARCHIVES

New Predictive Score May Help In Planning Adjuvant Therapy

This article is from The Cancer Letter archive.

Vol. 31 No. 9 | September 26, 2008

Download PDF Visit The Full Archive

Related Articles

Ibrutinib Produces 68% Overall Response Rate in Phase II Trial

January 25, 2013

Phase III Ramucirumab Trial Fails Primary Endpoint of PFS

October 25, 2013

ACS Updates Guidelines On Colorectal Screening.

February 2, 2001

FDA Should Delay Provenge Decision Pending Definitive Trial Results, ODAC Chairman Writes.

April 27, 2007

Officals: “Separations” in Normal Range as Critics Claim Brain Drain in the Clinic

January 17, 2014

Staff Advisory Boards To Be Formed; Three BSCs Proposed

August 11, 1995